{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T08:46:44Z","timestamp":1792226804580,"version":"4.4.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.neuropharm.2012.06.017","type":"journal-article","created":{"date-parts":[[2012,6,19]],"date-time":"2012-06-19T15:02:08Z","timestamp":1340118128000},"page":"202-209","source":"Crossref","is-referenced-by-count":74,"special_numbering":"C","title":["GABAergic activity in autism spectrum disorders: An investigation of cortical inhibition via transcranial magnetic stimulation"],"prefix":"10.1016","volume":"68","author":[{"given":"Peter G.","family":"Enticott","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayley A.","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole J.","family":"Rinehart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce J.","family":"Tonge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John L.","family":"Bradshaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul B.","family":"Fitzgerald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2012.06.017_bib1","doi-asserted-by":"crossref","first-page":"44","DOI":"10.5694\/j.1326-5377.2010.tb03403.x","article-title":"High-functioning pervasive developmental disorders in adults","volume":"192","author":"Abrahamson","year":"2010","journal-title":"Med. J. Australia"},{"key":"10.1016\/j.neuropharm.2012.06.017_bib2","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2302\/kjm.57.15","article-title":"Intersubjectivity, affective neuroscience, and the neurobiology of autistic spectrum disorders: a systematic review","volume":"57","author":"Aitken","year":"2008","journal-title":"Keio J. Med."},{"key":"10.1016\/j.neuropharm.2012.06.017_bib3","series-title":"Diagnostic and Statistical Manual of Mental Disorders \u2013 Text Revision","author":"American Psychiatric Association","year":"2000"},{"key":"10.1016\/j.neuropharm.2012.06.017_bib4","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1023\/A:1005653411471","article-title":"The Autism Spectrum Quotient (AQ): evidence from Asperger syndrome\/high functioning autism, males and females, scientists and mathematicians","volume":"31","author":"Baron-Cohen","year":"2001","journal-title":"J.\u00a0Autism Dev. Disord."},{"key":"10.1016\/j.neuropharm.2012.06.017_bib5","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.brs.2008.06.005","article-title":"Consensus paper on short-interval intracortical inhibition and other transcranial magnetic stimulation intracortical paradigms in movement disorders","volume":"1","author":"Berardelli","year":"2008","journal-title":"Brain Stimul."},{"key":"10.1016\/j.neuropharm.2012.06.017_bib6","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1212\/WNL.42.10.1951","article-title":"Magnetic brain stimulation: the silent period after the motor evoked potential","volume":"42","author":"Cantello","year":"1992","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2012.06.017_bib7","doi-asserted-by":"crossref","first-page":"5831","DOI":"10.1113\/jphysiol.2009.181834","article-title":"Motor cortex plasticity induced by paired associative stimulation is enhanced in physically active individuals","volume":"587","author":"Cirillo","year":"2009","journal-title":"J.\u00a0Physiol."},{"key":"10.1016\/j.neuropharm.2012.06.017_bib8","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.brainres.2010.09.101","article-title":"Brain growth across the life span in autism: age-specific changes in anatomical pathology","volume":"1380","author":"Courchesne","year":"2011","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2012.06.017_bib9","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.neubiorev.2010.10.002","article-title":"Evidence for GABAergic inhibitory deficits in major depressive disorder","volume":"35","author":"Croarkin","year":"2011","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2012.06.017_bib10","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1001\/archpsyc.59.4.347","article-title":"Evidence for impaired cortical inhibition in schizophrenia using transcranial magnetic stimulation","volume":"59","author":"Daskalakis","year":"2002","journal-title":"Arch. Gen. Psychiat."},{"key":"10.1016\/j.neuropharm.2012.06.017_bib11","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/S1388-2457(03)00038-5","article-title":"An automated method to determine the transcranial magnetic stimulation-induced contralateral silent period","volume":"114","author":"Daskalakis","year":"2003","journal-title":"Clin. Neurophys."},{"key":"10.1016\/j.neuropharm.2012.06.017_bib12","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1038\/npp.2008.22","article-title":"Long interval cortical inhibition from the dorsolateral prefrontal cortex: a TMS-EEG study","volume":"33","author":"Daskalakis","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2012.06.017_bib13","article-title":"Manual for the Developmental Behaviour Checklist","author":"Einfeld","year":"2002"},{"key":"10.1016\/j.neuropharm.2012.06.017_bib14","doi-asserted-by":"crossref","first-page":"e179","DOI":"10.1111\/j.1469-8749.2010.03665.x","article-title":"A\u00a0preliminary transcranial magnetic stimulation study of cortical inhibition and excitability in high-functioning autism and Asperger's disorder","volume":"52","author":"Enticott","year":"2010","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.neuropharm.2012.06.017_bib15","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1093\/brain\/awq046","article-title":"Evidence for gamma inhibition deficits in the dorsolateral prefrontal cortex of patients with schizophrenia","volume":"133","author":"Farzan","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2012.06.017_bib16","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s12311-008-0075-3","article-title":"Expression of GABA(B) receptors is altered in brains of subjects with autism","volume":"8","author":"Fatemi","year":"2009","journal-title":"Cerebellum"},{"key":"10.1016\/j.neuropharm.2012.06.017_bib17","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s10803-008-0646-7","article-title":"GABA(A) receptor downregulation in brains of subjects with autism","volume":"39","author":"Fatemi","year":"2009","journal-title":"J.\u00a0Autism Dev. Disord."},{"key":"10.1016\/j.neuropharm.2012.06.017_bib18","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s10803-009-0924-z","article-title":"mRNA and protein levels for GABAAalpha4, alpha5, beta1 and GABABR1 receptors are altered in brains from subjects with autism","volume":"40","author":"Fatemi","year":"2010","journal-title":"J.\u00a0Autism Dev. Disord."},{"key":"10.1016\/j.neuropharm.2012.06.017_bib19","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0165-1781(03)00094-5","article-title":"A\u00a0transcranial magnetic stimulation study of abnormal cortical inhibition in schizophrenia","volume":"118","author":"Fitzgerald","year":"2003","journal-title":"Psychiat. Res."},{"key":"10.1016\/j.neuropharm.2012.06.017_bib20","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1177\/155005940803900304","article-title":"Cortical inhibition in motor and non-motor regions: a combined TMS-EEG study","volume":"39","author":"Fitzgerald","year":"2008","journal-title":"Clin. EEG Neurosci."},{"key":"10.1016\/j.neuropharm.2012.06.017_bib21","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1038\/npp.2009.71","article-title":"A\u00a0transcranial magnetic stimulation study of the effects of cannabis use on motor cortical inhibition and excitability","volume":"34","author":"Fitzgerald","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2012.06.017_bib22","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/j.biopsych.2005.02.022","article-title":"Transcranial magnetic stimulation-evoked cortical inhibition: a consistent marker of attention-deficit\/hyperactivity disorder scores in tourette syndrome","volume":"57","author":"Gilbert","year":"2005","journal-title":"Biol. Psychiat."},{"key":"10.1016\/j.neuropharm.2012.06.017_bib23","series-title":"ANOVA: Repeated Measures","author":"Girden","year":"1992"},{"key":"10.1016\/j.neuropharm.2012.06.017_bib24","doi-asserted-by":"crossref","first-page":"591","DOI":"10.2217\/fnl.09.29","article-title":"Pathogenesis of autism: a patchwork of genetic causes","volume":"4","author":"Grigorenko","year":"2009","journal-title":"Fut. Neurol."},{"key":"10.1016\/j.neuropharm.2012.06.017_bib25","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s10803-006-0226-7","article-title":"[3H]-flunitrazepam-labeled benzodiazepine binding sites in the hippocampal formation in autism: a multiple concentration autoradiographic study","volume":"37","author":"Guptill","year":"2007","journal-title":"J.\u00a0Autism Dev. Disord."},{"key":"10.1016\/j.neuropharm.2012.06.017_bib26","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1093\/cercor\/bhj069","article-title":"Anatomical differences in the mirror neuron system and social cognition network in autism","volume":"16","author":"Hadjikhani","year":"2006","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.neuropharm.2012.06.017_bib27","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s10803-010-1065-0","article-title":"Non-invasive evaluation of the GABAergic\/glutamatergic system in autistic patients observed by MEGA-editing proton MR spectroscopy using a clinical 3 tesla instrument","volume":"41","author":"Harada","year":"2011","journal-title":"J.\u00a0Autism Dev. Disord."},{"key":"10.1016\/j.neuropharm.2012.06.017_bib28","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1023\/A:1010715619091","article-title":"Suppressed GABAergic inhibition as a common factor in suspected etiologies of autism","volume":"31","author":"Hussman","year":"2001","journal-title":"J.\u00a0Autism Dev. Disord."},{"key":"10.1016\/j.neuropharm.2012.06.017_bib29","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/BF00229631","article-title":"Effects of diazepam, baclofen and thiopental on the silent period evoked by transcranial magnetic stimulation in humans","volume":"109","author":"Inghilleri","year":"1996","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.neuropharm.2012.06.017_bib30","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s00221-006-0402-1","article-title":"Lorazepam-induced effects on silent period and corticomotor excitability","volume":"173","author":"Kimiskidis","year":"2006","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.neuropharm.2012.06.017_bib31","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1016\/j.neuroimage.2008.01.019","article-title":"The cortical motor threshold reflects microstructural properties of cerebral white matter","volume":"40","author":"Kloppel","year":"2008","journal-title":"Neuroimage"},{"key":"10.1016\/j.neuropharm.2012.06.017_bib32","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1113\/jphysiol.1993.sp019912","article-title":"Corticocortical inhibition in human motor cortex","volume":"471","author":"Kujirai","year":"1993","journal-title":"J.\u00a0Physiol."},{"key":"10.1016\/j.neuropharm.2012.06.017_bib33","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.biopsych.2009.09.025","article-title":"Evidence of cortical inhibitory deficits in major depressive disorder","volume":"67","author":"Levinson","year":"2010","journal-title":"Biol. Psychiat."},{"key":"10.1016\/j.neuropharm.2012.06.017_bib34","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1001\/archpsyc.61.3.291","article-title":"Investigation of neuroanatomical differences between autism and Asperger syndrome","volume":"61","author":"Lotspeich","year":"2004","journal-title":"Arch. Gen. Psychiat."},{"key":"10.1016\/j.neuropharm.2012.06.017_bib35","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1017\/S0033291709005728","article-title":"Differential effects on white-matter systems in high-functioning autism and Asperger's disorder","volume":"39","author":"McAlonan","year":"2009","journal-title":"Psychol. Med."},{"key":"10.1016\/j.neuropharm.2012.06.017_bib36","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/S0006-3223(00)01039-8","article-title":"The transcranial magnetic stimulation motor threshold depends on the distance from coil to underlying cortex: a replication in healthy adults comparing two methods of assessing the distance to cortex","volume":"49","author":"McConnell","year":"2001","journal-title":"Biol. Psychiat."},{"key":"10.1016\/j.neuropharm.2012.06.017_bib37","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s00221-006-0365-2","article-title":"The role of GABA(B) receptors in intracortical inhibition in the human motor cortex","volume":"173","author":"McDonnell","year":"2006","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.neuropharm.2012.06.017_bib38","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0304-3940(00)00980-0","article-title":"Deficient intracortical inhibition in drug-naive children with attention-deficit hyperactivity disorder is enhanced by methylphenidate","volume":"284","author":"Moll","year":"2000","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2012.06.017_bib39","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/aur.88","article-title":"Decreased GABAA receptors and benzodiazepine binding sites in the anterior cingulate cortex in autism","volume":"2","author":"Oblak","year":"2009","journal-title":"Autism Res."},{"key":"10.1016\/j.neuropharm.2012.06.017_bib40","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.brainres.2010.09.028","article-title":"Early functional brain development in autism and the promise of sleep fMRI","volume":"1380","author":"Pierce","year":"2011","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2012.06.017_bib41","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s00787-006-0530-y","article-title":"Gait function in high-functioning autism and Asperger's disorder: evidence for basal-ganglia and cerebellar involvement?","volume":"15","author":"Rinehart","year":"2006","journal-title":"Euro. Child Adol. Psychiat."},{"key":"10.1016\/j.neuropharm.2012.06.017_bib42","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s10803-007-0380-6","article-title":"A\u00a0scale to assist the diagnosis of autism and Asperger's disorder in adults (RAADS): a pilot study","volume":"38","author":"Ritvo","year":"2008","journal-title":"J.\u00a0Autism Dev. Disord."},{"key":"10.1016\/j.neuropharm.2012.06.017_bib43","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1002\/(SICI)1097-4598(199809)21:9<1209::AID-MUS15>3.0.CO;2-M","article-title":"Continuous intrathecal baclofen infusions induced a marked increase of the transcranially evoked silent period in a patient with generalized dystonia","volume":"21","author":"Siebner","year":"1998","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.neuropharm.2012.06.017_bib44","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.neuron.2010.10.004","article-title":"The genetics of child psychiatric disorders: focus on autism and Tourette syndrome","volume":"68","author":"State","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2012.06.017_bib45","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.brainres.2010.11.076","article-title":"Structural and functional magnetic resonance imaging of autism spectrum disorders","volume":"1380","author":"Stigler","year":"2011","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2012.06.017_bib46","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1080\/87565640903265178","article-title":"Autism and EEG phase reset: deficient GABA mediated inhibition in thalamo-cortical circuits","volume":"34","author":"Thatcher","year":"2009","journal-title":"Dev. Neuropsych."},{"key":"10.1016\/j.neuropharm.2012.06.017_bib47","doi-asserted-by":"crossref","first-page":"R84","DOI":"10.1016\/j.cub.2005.01.022","article-title":"Impaired motor facilitation during action observation in individuals with autism spectrum disorder","volume":"15","author":"Theoret","year":"2005","journal-title":"Curr. Biol."},{"key":"10.1016\/j.neuropharm.2012.06.017_bib48","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1136\/jmg.2005.039693","article-title":"An inversion inv(4)(p12-p15.3) in autistic siblings implicates the 4p GABA receptor gene cluster","volume":"43","author":"Vincent","year":"2006","journal-title":"J.\u00a0Med. Genet."},{"issue":"Pt 2","key":"10.1016\/j.neuropharm.2012.06.017_bib49","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/j.1469-7793.1999.0591t.x","article-title":"Differential effects on motorcortical inhibition induced by blockade of GABA uptake in humans","volume":"517","author":"Werhahn","year":"1999","journal-title":"J.\u00a0Physiol."},{"key":"10.1016\/j.neuropharm.2012.06.017_bib50","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/aur.62","article-title":"Decreased GAD65 mRNA levels in select subpopulations of neurons in the cerebellar dentate nuclei in autism: an in situ hybridization study","volume":"2","author":"Yip","year":"2009","journal-title":"Autism Res."},{"key":"10.1016\/j.neuropharm.2012.06.017_bib51","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/ana.410400306","article-title":"Effects of antiepileptic drugs on motor cortex excitability in humans: a transcranial magnetic stimulation study","volume":"40","author":"Ziemann","year":"1996","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2012.06.017_bib52","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S1567-424X(09)70226-0","article-title":"Pharmacology of TMS","volume":"56","author":"Ziemann","year":"2003","journal-title":"Suppl. Clin. Neurophysiol."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390812002754?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390812002754?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,4,5]],"date-time":"2021-04-05T10:53:30Z","timestamp":1617620010000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390812002754"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":52,"alternative-id":["S0028390812002754"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2012.06.017","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]}}}